Apnar Pharma Private Limited – FDA Inspection, Sep 11, 2026

Record Details

This FDA Inspection record concerns Apnar Pharma Private Limited, with an inspection on September 11, 2026, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Apnar Pharma Private Limited
Inspection Date: September 11, 2026
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Tanya R. Syffrard (Issuing Officer)

View Company Profile

ID · 3b244891-8ccd-4082-a092-497c806a79c1

Inspection Facts

Inspection number: 1335180
FDA center: Human Drugs
Project area: Drug Quality Assurance
Outcome: Form 483 issued, view the record

FDA Citations

FDCA 582(b)(4)Systems in place to comply with verification requirements

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Apnar Pharma Private Limited

FDA Inspection

Apnar Pharma Private LimitedSeptember 11, 2026